PT2167042E - Composições de aerossóis farmacêuticas compreendendo fluticasona - Google Patents
Composições de aerossóis farmacêuticas compreendendo fluticasona Download PDFInfo
- Publication number
- PT2167042E PT2167042E PT87626206T PT08762620T PT2167042E PT 2167042 E PT2167042 E PT 2167042E PT 87626206 T PT87626206 T PT 87626206T PT 08762620 T PT08762620 T PT 08762620T PT 2167042 E PT2167042 E PT 2167042E
- Authority
- PT
- Portugal
- Prior art keywords
- fluticasone
- aerosol compositions
- pharmaceutical aerosol
- pharmaceutical
- compositions
- Prior art date
Links
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 title 1
- 229960002714 fluticasone Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000008249 pharmaceutical aerosol Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0712454.8A GB0712454D0 (en) | 2007-06-27 | 2007-06-27 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2167042E true PT2167042E (pt) | 2015-12-21 |
Family
ID=38420793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT87626206T PT2167042E (pt) | 2007-06-27 | 2008-06-27 | Composições de aerossóis farmacêuticas compreendendo fluticasona |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9526790B2 (pt) |
| EP (1) | EP2167042B1 (pt) |
| AU (1) | AU2008269528B2 (pt) |
| CA (1) | CA2694238C (pt) |
| ES (1) | ES2554984T3 (pt) |
| GB (1) | GB0712454D0 (pt) |
| PL (1) | PL2167042T3 (pt) |
| PT (1) | PT2167042E (pt) |
| WO (1) | WO2009001144A2 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3111682A1 (en) * | 2014-06-26 | 2015-12-30 | Island Breeze Systems Ca, Llc | Mdi related products and methods of use |
| EP3174522A1 (en) | 2014-07-29 | 2017-06-07 | 3M Innovative Properties Company | Method of preparing a pharmaceutical composition |
| CA3037107C (en) * | 2016-09-19 | 2021-05-18 | Mexichem Fluor S.A. De C.V. | Stable pharmaceutical compositions comprising salmeterol and 1,1-difluoroethane (hfa-152a) suitable for use in metered dose inhalers (mdis) |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE887518A (fr) * | 1980-02-15 | 1981-08-13 | Glaxo Group Ltd | Cartothioates d'androstanes |
| US4352789A (en) * | 1980-03-17 | 1982-10-05 | Minnesota Mining And Manufacturing Company | Aerosol compositions containing finely divided solid materials |
| GB8828477D0 (en) | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
| IE67185B1 (en) | 1990-02-02 | 1996-03-06 | Fisons Plc | Propellant compositions |
| SK392592A3 (en) | 1990-06-29 | 1994-07-06 | Fisons Plc | Pressure aerosol composition |
| US5182097A (en) * | 1991-02-14 | 1993-01-26 | Virginia Commonwealth University | Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content |
| DE69233659T2 (de) | 1991-06-10 | 2007-09-13 | Schering Corp. | Fluorchlorkohlenwasserstofffreie Aerosolformulierungen |
| US6123924A (en) * | 1991-09-25 | 2000-09-26 | Fisons Plc | Pressurized aerosol inhalation compositions |
| IL103238A (en) | 1991-09-25 | 1995-07-31 | Fisons Plc | Pressurised aerosol compositions |
| DK0616525T3 (da) | 1991-12-12 | 1996-01-08 | Glaxo Group Ltd | Medikamenter |
| IL104068A (en) | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant |
| GB9419536D0 (en) * | 1994-09-28 | 1994-11-16 | Glaxo Inc | Medicaments |
| GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
| GB2326334A (en) | 1997-06-13 | 1998-12-23 | Chiesi Farma Spa | Pharmaceutical aerosol compositions |
| US7521068B2 (en) * | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
| US6261539B1 (en) * | 1998-12-10 | 2001-07-17 | Akwete Adjei | Medicinal aerosol formulation |
| GB2354007B (en) * | 1999-09-11 | 2003-10-22 | Glaxo Group Ltd | Pharmaceutical formulation of fluticasone propionate |
| WO2001047493A1 (en) * | 1999-12-24 | 2001-07-05 | Glaxo Group Limited | Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
| US6787532B2 (en) * | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
| SE0200312D0 (sv) * | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
| CA2474690A1 (en) | 2002-02-01 | 2003-08-07 | Astrazeneca Ab | Composition for inhalation |
| US20040208833A1 (en) | 2003-02-04 | 2004-10-21 | Elan Pharma International Ltd. | Novel fluticasone formulations |
| GB0328630D0 (en) * | 2003-12-10 | 2004-01-14 | Medpharm Ltd | Metered dose inhalation preparations |
| DE602004019232D1 (de) * | 2004-11-19 | 2009-03-12 | Kpss Kao Gmbh | Aerosolprodukt zur Haarbehandlung enthaltend amphoterische sowie nichtionische Polymere |
| EA200701987A1 (ru) * | 2005-03-16 | 2008-02-28 | Элан Фарма Интернэшнл Лтд. | Составы из нанодисперсного антагониста лейкотриеновых рецепторов/кортикостероида |
| WO2006102494A2 (en) | 2005-03-23 | 2006-09-28 | Elan Pharma International Limited | Nanoparticulate corticosteroid and antihistamine formulations |
| DE102006053374A1 (de) | 2006-02-09 | 2007-08-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz |
-
2007
- 2007-06-27 GB GBGB0712454.8A patent/GB0712454D0/en not_active Ceased
-
2008
- 2008-06-27 PT PT87626206T patent/PT2167042E/pt unknown
- 2008-06-27 WO PCT/GB2008/050518 patent/WO2009001144A2/en not_active Ceased
- 2008-06-27 EP EP08762620.6A patent/EP2167042B1/en active Active
- 2008-06-27 US US12/666,001 patent/US9526790B2/en active Active
- 2008-06-27 PL PL08762620T patent/PL2167042T3/pl unknown
- 2008-06-27 CA CA2694238A patent/CA2694238C/en not_active Expired - Fee Related
- 2008-06-27 ES ES08762620.6T patent/ES2554984T3/es active Active
- 2008-06-27 AU AU2008269528A patent/AU2008269528B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2554984T3 (es) | 2015-12-28 |
| WO2009001144A3 (en) | 2009-03-19 |
| US20110020244A1 (en) | 2011-01-27 |
| CA2694238A1 (en) | 2008-12-31 |
| CA2694238C (en) | 2013-02-12 |
| AU2008269528B2 (en) | 2013-05-16 |
| US9526790B2 (en) | 2016-12-27 |
| WO2009001144A2 (en) | 2008-12-31 |
| EP2167042A2 (en) | 2010-03-31 |
| AU2008269528A1 (en) | 2008-12-31 |
| EP2167042B1 (en) | 2015-09-09 |
| PL2167042T3 (pl) | 2016-02-29 |
| GB0712454D0 (en) | 2007-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL247741A0 (en) | pharmaceutical preparations | |
| EP2001498A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| IL194176A0 (en) | Pharmaceutical compositions | |
| GB0713625D0 (en) | Pharmaceutical compositions | |
| EP2222313A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| EP2124556A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| SI2966175T1 (sl) | Farmacevtski sestavki vsebujoči korteksolon-17-alfa-propionat | |
| IL200885A (en) | A history of mannich-based compounds and pharmacological preparations including them | |
| ZA201103347B (en) | Pharmaceutical aerosol composition | |
| GB0608724D0 (en) | Novel Pharmaceutical Compositions | |
| EP2146695A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| GB0707127D0 (en) | Pharmaceutical compositions | |
| GB0709811D0 (en) | Pharmaceutical compositions | |
| GB0610322D0 (en) | Novel pharmaceutical compositions | |
| GB0716907D0 (en) | Pharmaceutical powder compositions | |
| PT2167042E (pt) | Composições de aerossóis farmacêuticas compreendendo fluticasona | |
| GB2454923B (en) | Pharmaceutical compositions | |
| IL201394A0 (en) | Niacin - based pharmaceutical compositions | |
| HU0700755D0 (en) | Pharmaceutical compositions containing capsaicionid | |
| GB0706657D0 (en) | Pharmaceutical compositions | |
| GB0709603D0 (en) | Pharmaceutical compositions | |
| HU0600938D0 (en) | Pharmaceutical compositions | |
| ZA200808030B (en) | Pharmaceutical compositions | |
| GB0622964D0 (en) | Pharmaceutical compositions | |
| GB0621623D0 (en) | Pharmaceutical compositions |